The clinical significance of early histological rejection with or without biochemical abnormality in adult living donor liver transplantation for hepatitis B virus related end stage liver disease

Transplant International

Volumn 20, Issue 1, 2007, Pages 37-44

  Cho, Jai Young ^b   Suh, Kyung Suk ^a,b   Lee, Hae Won ^b   Cho, Eung Ho ^b   Yang, Sung Hoon ^b   Cho, Yong Beom ^b   Yi, Nam Joon ^b   Kim, Min A ^b   Jang, Ja June ^b   Lee, Kuhn Uk ^b  

^a Seoul National University Hospital   (South Korea)

^b Seoul National University College of Medicine   (South Korea)

Author keywords

Assessment; Biopsy; Outcomes; Prognosis; Risk factors; Survival

Indexed keywords

CALCINEURIN INHIBITOR; CORTICOSTEROID; CYCLOSPORIN; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; TACROLIMUS;

ADULT; AGED; ARTICLE; BIOCHEMISTRY; CONFIDENCE INTERVAL; CONTROLLED STUDY; DONOR SELECTION; FEMALE; GRAFT FAILURE; GRAFT SURVIVAL; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; HUMAN TISSUE; LIVER FAILURE; LIVER GRAFT REJECTION; LIVER HISTOLOGY; LIVER TRANSPLANTATION; LIVING DONOR; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR;

EID: 33845670000     PISSN: 09340874     EISSN: 14322277     Source Type: Journal    
DOI: 10.1111/j.1432-2277.2006.00384.x     Document Type: Article

References (21)

1. Matas AJ, Gillingham KJ, Payne WD, Najarian JS. The impact of an acute rejection episode on long-term renal allograft survival (t1/2). Transplantation 1994; 57: 857.
2. Seiler CA, Renner EL, Czerniak A, Didonna D, Buchler MW, Reichen J. Early acute cellular rejection: no effect on late hepatic allograft function in man. Transpl Int 1999; 12: 195.
3. Demetris A, Adams D, Bellamy C, et al. Update of the International Banff Schema for liver allograft rejection: working recommendations for the histopathologic staging and reporting of chronic rejection. An International Panel. Hepatology 2000; 31: 792.
4. Neil DA, Hubscher SG. Are parenchymal changes in early post-transplant biopsies related to preservation-reperfusion injury or rejection? Transplantation 2001; 71: 1566.
5. Suh KS, Kim SB, Chang SH, et al. Significance of positive cytotoxic cross-match in adult-to-adult living donor liver transplantation using small graft volume. Liver Transpl 2002; 8: 1109.
6. Demetris AJ, Batts KP, Dhillon AP, et al. Banff schema for grading liver allograft rejection: an international consensus document. Hepatology 1997; 25: 658.
7. Heneghan MA, Zolfino T, Muiesan P, et al. An evaluation of long-term outcomes after liver transplantation for cryptogenic cirrhosis. Liver Transpl 2003; 9: 921.
8. Henley KS, Lucey MR, Appelman HD, et al. Biochemical and histopathological correlation in liver transplant: the first 180 days. Hepatology 1992; 16: 688.
9. Aran PP, Bissel MG, Whitington PF, Bostwick DG, Adamac T, Baker AL. Diagnosis of hepatic allograft rejection: role of liver biopsy. Clin Transplant 1993; 7: 475.
10. Wiesner RH. Is hepatic histology the true gold standard in diagnosing acute hepatic allograft rejection? Liver Transpl Surg 1996; 2: 165.
11. Neuberger J, Wilson P, Adams D. Protocol liver biopsies: the case in favour. Transplant Proc 1998; 30: 1497.
12. Tippner C, Nashan B, Hoshino K, et al. Clinical and subclinical acute rejection early after liver transplantation: contributing factors and relevance for the long-term course. Transplantation 2001; 72: 1122.
13. Neuberger J. Incidence, timing, and risk factors for acute and chronic rejection. Liver Transpl Surg 1999; 5: S30.
14. Kamada N, Teramoto K, Baguerizo A, Ishikawa M, Sumimoto R, Ohkouchi Y. Cellular basis of transplantation tolerance induced by liver grafting in the rat. Extent of clonal deletion among thoracic duct lymphocytes, spleen, and lymph node cells. Transplantation 1988; 46: 165.
15. Bartlett AS, Ramadas R, Furness S, Gane E, McCall JL. The natural history of acute histologic rejection without biochemical graft dysfunction in orthotopic liver transplantation: a systematic review. Liver Transpl 2002; 8: 1147.
16. Adams DH, Hubscher SG, Neuberger JM, McMaster P, Elias E, Buckels JA. Reduced incidence of rejection in patients undergoing liver transplantation for chronic hepatitis B. Transplant Proc 1991; 23: 1436.
17. Farges O, Nocci Kalil A, Sebagh M, Reynes M, Bismuth H. Low incidence of chronic rejection in patients experiencing histological acute rejection without simultaneous impairment in liver function tests. Transplant Proc 1995; 27: 1142.
18. Kwekkeboom J, Tha-In T, Tra WM, et al. Hepatitis B immunoglobulins inhibit dendritic cells and T cells and protect against acute rejection after liver transplantation. Am J Transplant 2005; 5: 2393.
19. Farges O, Saliba F, Farhamant H, et al. Incidence of rejection and infection after liver transplantation as a function of the primary disease: possible influence of alcohol and polyclonal immunoglobulins. Hepatology 1996; 23: 240.
20. Knechtle SJ, Wolfe JA, Burchette J, Sanfilippo F, Bollinger RR. Infiltrating cell phenotypes and patterns associated with hepatic allograft rejection or acceptance. Transplantation 1987; 43: 169.
21. Larson AM, Chan GC, Wartelle CF, et al. Infection complicating percutaneous liver biopsy in liver transplant recipients. Hepatology 1997; 26: 1406.